Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China flag China · Delayed Price · Currency is CNY
12.70
+0.26 (2.09%)
Sep 30, 2026, 3:04 PM CST

SHE:301211 Statistics

Total Valuation

SHE:301211 has a market cap or net worth of CNY 5.30 billion. The enterprise value is 3.77 billion.

Market Cap5.30B
Enterprise Value 3.77B

Important Dates

The next confirmed earnings date is Tuesday, October 27, 2026.

Earnings Date Oct 27, 2026
Ex-Dividend Date Jun 12, 2026

Share Statistics

SHE:301211 has 417.60 million shares outstanding. The number of shares has decreased by -4.81% in one year.

Current Share Class 417.60M
Shares Outstanding 417.60M
Shares Change (YoY) -4.81%
Shares Change (QoQ) -13.19%
Owned by Insiders (%) 14.75%
Owned by Institutions (%) 0.82%
Float 167.32M

Valuation Ratios

The trailing PE ratio is 114.66.

PE Ratio 114.66
Forward PE n/a
PS Ratio 11.38
PB Ratio 2.33
P/TBV Ratio 2.40
P/FCF Ratio n/a
P/OCF Ratio 166.58
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 80.98
EV / Sales 8.08
EV / EBITDA 68.34
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 17.65, with a Debt / Equity ratio of 0.00.

Current Ratio 17.65
Quick Ratio 16.09
Debt / Equity 0.00
Debt / EBITDA 0.03
Debt / FCF -0.07
Interest Coverage 74.07

Financial Efficiency

Return on equity (ROE) is 2.05% and return on invested capital (ROIC) is 1.13%.

Return on Equity (ROE) 2.05%
Return on Assets (ROA) 0.26%
Return on Invested Capital (ROIC) 1.13%
Return on Capital Employed (ROCE) 0.43%
Weighted Average Cost of Capital (WACC) 7.22%
Revenue Per Employee 489,553
Profits Per Employee 48,844
Employee Count952
Asset Turnover 0.19
Inventory Turnover 2.84

Taxes

In the past 12 months, SHE:301211 has paid 7.63 million in taxes.

Income Tax 7.63M
Effective Tax Rate 14.10%

Stock Price Statistics

The stock price has increased by +6.81% in the last 52 weeks. The beta is 0.54, so SHE:301211's price volatility has been lower than the market average.

Beta (5Y) 0.54
52-Week Price Change +6.81%
50-Day Moving Average 11.78
200-Day Moving Average 11.88
Relative Strength Index (RSI) 58.36
Average Volume (20 Days) 9,888,402

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHE:301211 had revenue of CNY 466.05 million and earned 46.50 million in profits. Earnings per share was 0.11.

Revenue466.05M
Gross Profit 103.69M
Operating Income 9.80M
Pretax Income 54.13M
Net Income 46.50M
EBITDA 54.13M
EBIT 9.80M
Earnings Per Share (EPS) 0.11
Full Income Statement

Balance Sheet

The company has 1.54 billion in cash and 1.92 million in debt, with a net cash position of 1.54 billion or 3.68 per share.

Cash & Cash Equivalents 1.54B
Total Debt 1.92M
Net Cash 1.54B
Net Cash Per Share 3.68
Equity (Book Value) 2.28B
Book Value Per Share 5.46
Working Capital 1.68B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 31.84 million and capital expenditures -61.20 million, giving a free cash flow of -29.36 million.

Operating Cash Flow 31.84M
Capital Expenditures -61.20M
Depreciation & Amortization 44.33M
Net Borrowing -1.85M
Free Cash Flow -29.36M
FCF Per Share -0.07
Full Cash Flow Statement

Margins

Gross margin is 22.25%, with operating and profit margins of 2.10% and 9.98%.

Gross Margin 22.25%
Operating Margin 2.10%
Pretax Margin 11.62%
Profit Margin 9.98%
EBITDA Margin 11.61%
EBIT Margin 2.10%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 0.47%.

Dividend Per Share 0.06
Dividend Yield 0.47%
Dividend Growth (YoY) -65.20%
Years of Dividend Growth n/a
Payout Ratio 53.88%
FCF Payout Ratio n/a
Buyback Yield 4.81%
Shareholder Yield 5.29%
Earnings Yield 0.88%
FCF Yield -0.55%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 27, 2025. It was a forward split with a ratio of 1.45.

Last Split Date Aug 27, 2025
Split Type Forward
Split Ratio 1.45

Scores

SHE:301211 has an Altman Z-Score of 28.64 and a Piotroski F-Score of 6.

Altman Z-Score 28.64
Piotroski F-Score 6